Grants for County governments - Health

The Southern Sustainable Agriculture Research & Education (SSARE) Education Grants program is designed to fund education and outreach activities that benefit the sustainable agriculture community. This grant directly aligns with SSARE's mission to promote efforts in farmer innovations, community resilience, business success, agricultural diversification, and best management practices. The core objective is to support projects that develop sustainable agriculture systems or move existing systems towards sustainability. The primary beneficiaries of these grants are farmers and farming communities, including those involved in indigenous agriculture producing for community food systems. Academic institutions, non-profits, non-governmental organizations (NGOs), 1890 land-grant university faculty/extension cooperators, 1862 land-grant universities, other colleges and universities, and government agencies are eligible to apply, acting as facilitators for these educational initiatives. The impact goals are centered on fostering a more sustainable, resilient, and economically viable agricultural sector through knowledge dissemination and practical application. Education Grants prioritize projects that clearly articulate what is being taught, to whom, and how the goals will be accomplished. Focus areas include experiential learning (demonstrations, on-farm tours, field days, workshops), integrative approaches (conferences, seminars, course curriculum), and reinforcement methods (fact sheets, bulletins, videos, online technologies). SSARE also encourages proposals on quality of life topics, such as heirs property, farmers’ markets, food hubs, local/regional processing, and urban agriculture systems, emphasizing the social health of farming systems. Expected outcomes include the adoption of sustainable agriculture practices, enhanced farmer innovation, increased community resilience, improved business success for agricultural enterprises, and greater agricultural diversification. Projects should yield results that are realistic, acceptable to farmers, logical, and capable of leading to tangible actions and benefits described in the proposal. The grant projects are strictly focused on education and outreach, with no research component, and are paid by reimbursement of allowable expenses. The foundation's strategic priorities are evident in the grant requirements, which mandate that project outcomes focus on sustainable agriculture systems and clearly demonstrate how education and outreach efforts will be implemented and evaluated. The theory of change underpinning this program is that by providing targeted education and outreach, knowledge and best practices will be transferred to farmers and communities, leading to the development and widespread adoption of sustainable agricultural methods and improved quality of life within farming systems. Project maximums are $50,000, with a duration limited to two years. Applicants from the Southern region, including Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, Puerto Rico, and the U.S. Virgin Islands, are eligible. Farmers involved in these projects must have farming/ranching as their primary occupation or part-time farming with at least $1,000 of documented annual income from their operation, with exceptions for indigenous agriculture.

The Community Foundation of South Alabama (CFSA) offers competitive program grants to local nonprofits in Mobile, Baldwin, Escambia, Monroe, Conecuh, Choctaw, Clarke, and Washington Counties, Alabama. These grants are funded through the Foundation’s unrestricted and field of interest funds, established by donors to address critical community needs. The program aligns with CFSA's mission to support sustainable initiatives that produce meaningful results on community priorities. For 2024, the Foundation is exclusively awarding one-year program grants, focusing on specific projects that benefit the community and demonstrate potential for efficacy and sustainability. CFSA's grant-making is strategically guided by six key focus areas: Family, Education, Work, Racial Equity, Arts and Culture, and Mental and Behavioral Health, all within its eight-county footprint. For 2024, the Foundation has defined six specific priorities for grant applications. These include promoting parenting education; expanding opportunities for young people to secure well-paying jobs through workforce training; increasing access to preschool education and youth extracurricular activities; advancing racial equity with a focus on underprivileged youth; increasing youth access to equitable, high-quality arts and culture; and providing mental and behavioral supports for individuals and families. The target beneficiaries are individuals and families within the eight-county region, particularly underprivileged youth, who will directly benefit from these programs. The expected outcomes and measurable results revolve around the successful implementation of projects that address the stated priorities. CFSA seeks to support programs that can demonstrate a positive impact on community priorities and needs. While specific measurable results are not explicitly detailed for each priority, the emphasis on "meaningful results" and "efficacy and sustainability" suggests that applicants will need to articulate their intended outcomes and how they will measure success. For instance, programs focusing on workforce training would aim for increased job placement rates, while those on preschool education would look at improved school readiness. The Foundation's theory of change is implicitly rooted in the belief that by funding targeted programs within its six focus areas, it can create a ripple effect of positive change across the eight-county region. By supporting initiatives that promote parenting education, workforce development, early childhood education, youth engagement in arts and culture, racial equity, and mental health, CFSA aims to foster a more resilient, equitable, and thriving community. The preference for programs not exceeding 50% of their total budget also indicates a strategic priority for diversified funding and community buy-in, ensuring broader impact and sustainability beyond CFSA's initial investment. Grant amounts range from $5,000 to $15,000, with requests not to exceed $15,000.

This funding opportunity supports postdoctoral researchers from underrepresented groups in cancer research as they transition to independent faculty positions, providing salary and research funding to help establish their own research programs.

This funding opportunity supports organizations that provide training for mental health paraprofessionals to enhance their skills in serving children and youth at risk for behavioral health issues.

This funding opportunity provides financial support to rural health providers in New York to create and sustain collaborative networks that improve healthcare access and services for residents in rural areas.

This funding opportunity supports innovative clinical research to explore the brain mechanisms behind substance use disorders, targeting a wide range of researchers and institutions dedicated to addressing addiction challenges.

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.

The United Way of Jefferson & North Walworth Counties is offering its 2024 Pillar Grant Program, inviting applications from organizations, local businesses, community clubs, or individuals. This program aligns with the United Way's overarching mission to improve the health, education, and financial stability of all individuals within their communities. Proposals submitted for these grants must serve a public purpose and directly support this mission, focusing on key areas that address significant community needs. The Pillar Grant Program specifically targets communities within Jefferson County and the City of Whitewater, aiming to benefit residents by addressing critical social issues. The program seeks to make a strong, positive impact by funding creative and innovative projects that respond to identified community needs. While the grant details do not explicitly state a "theory of change," the program's structure implies that by investing in specific intervention areas, it will lead to improved community well-being and self-sufficiency. The core priorities and focuses of the Pillar Grants are clearly defined, emphasizing four key areas: early intervention care, mental health and AODA (alcohol and other drug addiction) treatment, overcoming barriers to self-sufficiency, and promoting diversity, equity, and inclusion. Applicants must ensure their proposed projects and programs directly align with one or more of these strategic areas, as they represent the United Way's commitment to addressing the most pressing challenges faced by the communities it serves. Expected outcomes include the accomplishment or initiation of projects within generally a one-year timeframe, leading to tangible improvements in the prioritized areas. While specific measurable results are not detailed in the program description, the emphasis on addressing community needs and providing a strong, positive impact suggests that successful proposals will demonstrate clear objectives and the potential for quantifiable improvements in early intervention, mental health, economic stability, and social equity within Jefferson County and Whitewater.

This funding opportunity provides financial support for researchers to analyze and integrate existing data to better understand cancer risk, prevention, and treatment outcomes, particularly focusing on innovative methodologies and addressing health disparities.

The FY24 PCRP Early Investigator Research Award supports prostate cancer-focused research opportunities for individuals in the early stages of their careers under the guidance of one or more designated mentors. This opportunity allows early-career investigators to develop a research project, investigate a problem or question in prostate cancer research, and further their intellectual development as prostate cancer researchers of the future. All application components for the FY24 PCRP Early Investigator Research Award are to be written by the Principal Investigator (PI), with appropriate direction from the mentor(s).Key elements of this award mechanism are as follows: Principal Investigator: The postdoctoral investigator is considered the PI of the application and must exhibit strong potential for and commitment to pursuing a career as an investigator at the forefront of prostate cancer research; however, the PI is not required to have previous prostate cancer research experience. The PI must have 3 years or less of postdoctoral research experience (excluding clinical residency or clinical fellowship training) as of March 31, 2025. The PCRP strongly encourages applications from PIs who demonstrate a commitment to pursuing a career focused on prostate cancer health disparity research. Mentor(s): Applications must include at least one mentor appropriate to the proposed research project who has experience in prostate cancer research and mentoring as demonstrated by a record of active funding, recent publications, and successful mentorship. The primary mentor can be a junior faculty member, in which case the PI is encouraged to include a secondary mentor with a more robust track record in prostate cancer research and mentorship. Applications that focus on prostate cancer health disparity should include at least one mentor with experience in prostate cancer health disparity research. The selected mentor(s) should also demonstrate a clear commitment to the development of the PI toward independence as a prostate cancer researcher. Research Approach: Proposed research ideas are required to address one or more of the FY24 PCRP Overarching Challenges. Projects that specifically address the FY24 PCRP Overarching Challenge to advance health equity and reduce disparities in prostate cancer are strongly encouraged. The scientific rationale and experimental methodology should demonstrate in-depth analysis of the research problem presented. The feasibility of the research design and methods should be well defined, and a clear plan should be articulated as to how the proposed goals of the project can be achieved. Inclusion of preliminary data relevant to prostate cancer and the proposed project is encouraged but not required. Any preliminary data provided should be from the PI, mentor(s), or member(s) of the collaborating team. Additionally, required resources should be identified and supported through documentation. Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this funding opportunity. Researcher Development Plan: The PI must outline an individualized, prostate cancer-focused researcher development plan, which should include a clearly articulated strategy for acquiring the necessary skills, competence, and expertise that will enable the PI to successfully complete the proposed research project and foster the PIs development as an independent prostate cancer researcher. An environment appropriate to the proposed mentoring and research project must be clearly described, although any deficiencies of resources and/or mentorship at the PIs institution can be mitigated through collaboration(s) with other institutions. If the PI will be utilizing resources at another institution to successfully complete the proposed project, then the PI is strongly encouraged to designate a co-mentor at the collaborating institution.Investigators are strongly encouraged to incorporate the following components into their study design, where appropriate, in order to maximize the potential impact of the proposed research project: authentication of proposed cell lines; statistical rigor of preclinical animal experiments; and incorporation of experiments to assess clinical relevance and translatability of findings. Studies utilizing data derived from large patient studies that include long-term health records, biospecimen repositories, and pre-existing research and apply state-of-the-art genomic and/or proteomic analysis, bioinformatics, and/or mathematical models to such data are also encouraged. Investigators are highly encouraged to provide a letter of support indicating access to and the availability of any resources required to support the study.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 PCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more-effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 (http://www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies.Clinical trials are not allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 PCRP Early Investigator Research Award should not exceed $300,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $6.24M to fund approximately 13 Early Investigator Research Award applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This program recognizes and honors influential leaders in Colorado's agriculture industry who have made significant contributions to various agricultural fields and community involvement.

This funding opportunity supports multidisciplinary research aimed at improving the understanding and treatment of asthma and allergic diseases, inviting applications from various institutions and organizations involved in clinical and translational research.

This grant provides funding to specialized clinics for collecting and analyzing long-term health data on individuals with spina bifida, aiming to improve care and health outcomes for patients of all ages.

This funding opportunity supports innovative research projects that explore how T-cells contribute to HIV infection and related brain complications, targeting researchers from various institutions and organizations.

This funding opportunity supports innovative educational projects that engage K-12 students and teachers in the biomedical and behavioral sciences, particularly targeting individuals from diverse and underrepresented backgrounds.

The purpose of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scientists trained in clinical and translational cancer research, and to promote their career development as cancer researchers. This Funding Opportunity Announcement (FOA) allows appointment of Scholars proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary study to an existing trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and thereby control the patent prosecution and licensing negotiations) for biotherapeutic candidates developed in this program.

The 2024 Parks, Fields, Trails Grant, funded by the Erie County Gaming Revenue Authority, offers $10,000 to $100,000 for capital projects that improve public parks, athletic fields, and trails in Erie County, Pennsylvania, aiming to promote healthy lifestyles, enhance local tourism, and rejuvenate neighborhoods, with a focus on projects that provide social, educational, cultural, health, recreation, and/or economic benefits to residents.

The purpose of this notice of funding opportunity (NOFO) is to solicit applications proposing innovative transdisciplinary research that integrates approaches across social/cognitive neuroscience and other social sciences and will lead to a testable conceptual or computational model that provides mechanistic insights into social behavior and its relationships with the onset, trajectory and impact of Substance Use Disorders (SUD) and comorbidities. This NOFO is specifically soliciting applications proposing BESH research, referred to in NOT-OD-18-212 as prospective basic science studies involving human participants. These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Application budgets are not limited but need to reflect the actual needs of the proposed project.

The "Short Courses on Utilizing the NIH Stage Model to Develop Behavioral Interventions to Promote Healthy Aging" grant aims to fund the creation of short educational programs that teach researchers how to use the NIH Stage Model to develop non-drug interventions that encourage healthy aging and improve care for older adults.